Vascular Biogenics Ltd.
Hedge Funds Holdings
Last updated:
Vascular Biogenics Ltd.‘s stocks are currently a part of 10 hedge funds’ portfolios, which represents 0.5% of the total amount of its stocks outstanding. This makes up a total of 328.66K shares of Vascular Biogenics Ltd.. Compared to the previous quarter, the number fell by -86.65% or -2.13M shares fewer. As for the holding position changes, 10% (1) of current hedge fund investors increased the number of shares held, 30% (3) of current holders sold a part of the shares held, and 50% (5) closed the holdings completely. 1 hedge funds are new holders of Vascular Biogenics Ltd. stock in Q1 2023, it is 10% of total holders.
Hedge funds holding Vascular Biogenics Ltd. (Q2 2018 – Q1 2023)
| Q2 2018 | 29 |
|---|---|
| Q3 2018 | 28 |
| Q4 2018 | 23 |
| Q1 2019 | 20 |
| Q2 2019 | 16 |
| Q3 2019 | 15 |
| Q4 2019 | 17 |
| Q1 2020 | 20 |
| Q2 2020 | 19 |
| Q3 2020 | 12 |
| Q4 2020 | 17 |
| Q1 2021 | 24 |
| Q2 2021 | 22 |
| Q3 2021 | 26 |
| Q4 2021 | 25 |
| Q1 2022 | 25 |
| Q2 2022 | 29 |
| Q3 2022 | 23 |
| Q4 2022 | 23 |
| Q1 2023 | 10 |
Hedge funds changes in Vascular Biogenics Ltd. positions (Q2 2018 – Q1 2023)
| Q2 2018 | 7 | 4 | 7 | 12 | -1 |
|---|---|---|---|---|---|
| Q3 2018 | 8 | 6 | 6 | 9 | -1 |
| Q4 2018 | 8 | 4 | 4 | 13 | -6 |
| Q1 2019 | 6 | 3 | 4 | 9 | -2 |
| Q2 2019 | 1 | 6 | 3 | 5 | 1 |
| Q3 2019 | 1 | 1 | 5 | 1 | 7 |
| Q4 2019 | 4 | 2 | 6 | 2 | 3 |
| Q1 2020 | 8 | 4 | 3 | 4 | 1 |
| Q2 2020 | 6 | 5 | 3 | 5 | 0 |
| Q3 2020 | 1 | 4 | 3 | 7 | -3 |
| Q4 2020 | 7 | 1 | 4 | 2 | 3 |
| Q1 2021 | 11 | 5 | 4 | 5 | -1 |
| Q2 2021 | 6 | 5 | 4 | 8 | -1 |
| Q3 2021 | 7 | 3 | 11 | 3 | 2 |
| Q4 2021 | 6 | 3 | 6 | 7 | 3 |
| Q1 2022 | 5 | 7 | 5 | 4 | 4 |
| Q2 2022 | 7 | 6 | 6 | 3 | 7 |
| Q3 2022 | 9 | 6 | 4 | 14 | -10 |
| Q4 2022 | 2 | 6 | 10 | 2 | 3 |
| Q1 2023 | 1 | 1 | 3 | 5 | 0 |
Hedge funds changes in Vascular Biogenics Ltd. stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 294,000 | 127,000 |
|---|---|---|
| Q3 2018 | 175,000 | 26,000 |
| Q4 2018 | 87,000 | 9,000 |
| Q1 2019 | 127,000 | 8,000 |
| Q2 2019 | 115,000 | 0 |
| Q3 2019 | 116,000 | 8,000 |
| Q4 2019 | 100,000 | 7,000 |
| Q1 2020 | 129,000 | 0 |
| Q2 2020 | 109,000 | 0 |
| Q3 2020 | 182,000 | 0 |
| Q4 2020 | 1,379,000 | 22,000 |
| Q1 2021 | 936,000 | 219,000 |
| Q2 2021 | 812,000 | 332,000 |
| Q3 2021 | 904,000 | 149,000 |
| Q4 2021 | 765,000 | 47,000 |
| Q1 2022 | 668,000 | 26,000 |
| Q2 2022 | 1,140,000 | 24,000 |
| Q3 2022 | 58,000 | 1,000 |
| Q4 2022 | 0 | 3,400 |
| Q1 2023 | 0 | 17,000 |